Latest Information

Radiofrequency Ablation, Partial Nephrectomy for RCC Offer Similar Long-Term Outcomes

January 11, 2012
In appropriately selected patients, radiofrequency ablation (RFA) is an effective minimally invasive treatment for cT1a renal cell carcinoma (RCC) that offers long-term oncologic outcomes comparable to nephron-sparing surgery, data show.

Ultrasound Not Inferior for Sizing Renal Masses

January 06, 2012
Ultrasound imaging works as well as computed tomography (CT) and magnetic resonance imaging (MRI) for evaluating renal mass size, a new study suggests.

Aveo Announces Kidney Cancer Drug Tivozanib Meets Late-Stage Goal

January 4, 2012
“The drug helped patients with advanced renal cell carcinoma live for 11.9 months without their disease progressing in a late-stage study, compared with 9.1 months for those on Nexavar [sorafenib].”

Donors & Supporters of the McMaster- SJH Kidney Cancer Centre of Excellence

Nancy Anne Pecora

Nancy Pecora was a former nurse at St. Joseph’s Healthcare and also worked as a critical care nurse in the ICU at the Greater Niagara General Hospital. She was very supportive of St. Joseph’s Hospital and a patient of the McMaster Institute of Urology for 10 years.

Nancy was a very grateful patient for all of the care she received through St. Joseph’s Hospital and the McMaster Institute of Urology, and as a staunch supporter she left her estate to the St. Joseph’s Healthcare Foundation in support of Kidney Cancer research.

The McMaster - St. Joseph’s Healthcare Kidney Cancer Centre of Excellence as well as the St. Joseph’s Healthcare Foundation are proud to honor Nancy Pecora’s faithful support and the lasting legacy she has made to enhance the care received by future kidney cancer patients treated here.

Menceles Family

More information soon.

Corporate Sponsors

Pfizer

Pfizer homepage

Novartis

Novartis homepage